August 13, 2020
August 13, 2020
Categories

Biomedical waste amid COVID-19: perspectives from Bangladesh (The Lancet)

The Lancet Md Mostafizur Rahman, Md Bodrud-Doza, Mark D Griffiths, Mohammed A Mamun 13 August, 2020 Biomedical waste is a threat to global public environmental health, […]
Do you like it?
Read more
August 4, 2020
August 4, 2020
Categories

COVID-19 and preschool wheeze care: lessons learned (The Lancet)

The Lancet Date: 04 August, 2020 Heidi Makrinioti, Mando Watson, Andrew Bush, Dougal Hargreaves Published:August 04, 2020 The pattern of increasing visits to the emergency department […]
Do you like it?
Read more
August 3, 2020
August 3, 2020
Categories

COVID-19 spread in the UK: the end of the beginning? (The Lancet)

The Lancet– Date: 03 August, 2020 Roy M Anderson, T Déirdre Hollingsworth, Rebecca F Baggaley, Rosie Maddren, Carolin Vegvari Published:August 03, 2020 As the UK Government […]
Do you like it?
Read more
July 31, 2020
July 31, 2020
Categories

Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study (The Lancet)

The Lancet– Date: 31 July, 2020 Long H Nguyen, MD, David A Drew, PhD, Mark S Graham, PhD, Amit D Joshi, PhD, Chuan-Guo Guo, MS, Wenjie […]
Do you like it?
Read more
July 20, 2020
July 20, 2020
Categories

Encouraging results from phase 1/2 COVID-19 vaccine trials (The Lancet)

The Lancet Date: 20 July, 2020 Dystopian realities generate utopian visions. The dramatic emergence of SARS-CoV-2 into our lives and the subsequent COVID-19 pandemic have spawned […]
Do you like it?
Read more
July 20, 2020
July 20, 2020
Categories

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (The Lancet)

The Lancet 20 July, 2020 Pedro M Folegatti, MSc, Katie J Ewer, PhD, Parvinder K Aley, PhD, Brian Angus, MD, Prof Stephan Becker, PhD, Sandra Belij-Rammerstorfer, […]
Do you like it?
Read more
July 20, 2020
July 20, 2020
Categories

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial (The Lancet)

The Lancet July 20, 2020 Feng-Cai Zhu, MSc, Prof Xu-Hua Guan, PhD, Prof Yu-Hua Li, PhD, Prof Jian-Ying Huang, MD, Prof Tao Jiang, PhD, Prof Li-Hua […]
Do you like it?
Read more
July 3, 2020
July 3, 2020
Categories

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics (The Lancet)

The Lancet Date: 03 July, 2020 Prof Eskild Petersen, MD, Prof Marion Koopmans, DVM, Unyeong Go, MD, Davidson H Hamer, MD, Nicola Petrosillo, MD, Prof Francesco […]
Do you like it?
Read more
July 1, 2020
July 1, 2020
Categories

Race for a COVID-19 vaccine (Elsevier)

The Lancet Race for a COVID-19 vaccineThe entire world is united in facing the emergency of the corona-virus disease 2019 (COVID-19) pandemic: we are at war, […]
Do you like it?
Read more
Load more